0 Комментарии
0 Поделились
287 Просмотры
0 предпросмотр
Поиск
Знакомьтесь и заводите новых друзей
-
Новости
- ECOSYSTEM
- ИССЛЕДОВАТЬ
-
Страницы
-
Группы
-
Мероприятия
-
Статьи пользователей
-
Войдите, чтобы отмечать, делиться и комментировать!
-
Breast Cancer Diagnostics Market Size, Share, Trends, Key Drivers, Growth Opportunities and Competitive OutlookBreast Cancer Diagnostics Market By Test Type (Imaging, Biopsy, Genomic Test, Blood Test, and Others), Type (Ductal In Situ Carcinoma, Invasive Ductal Carcinoma, Inflammatory Breast Cancer, and Metastatic Breast Cancer), End User (Hospitals, Clinics, Research and Academic Institutes, Diagnostic Centers, and Others) Distribution Channel (Direct Tender, Retail Sales, and Others) Industry...0 Комментарии 0 Поделились 242 Просмотры 0 предпросмотр
-
ESR1 Mutated Metastatic Breast Cancer Diagnostics Market Emerging OpportunitiesESR1 Mutated Metastatic Breast Cancer Diagnostics Market Size The ESR1 Mutated Metastatic Breast Cancer Diagnostics Market is an emerging, clinically important segment of oncology diagnostics driven by the need to detect acquired resistance to endocrine therapy in hormone-receptor (HR+) metastatic breast cancer. Market estimates place the diagnostics segment at roughly US$ 60–65 million...0 Комментарии 0 Поделились 789 Просмотры 0 предпросмотр